Preston Brice

Preston Brice General Information

Biography

Mr. Preston Brice serves as a Partner at Grant Avenue Capital. He serves as Board Member at Helios Clinical Research. Prior to Grant Avenue Capital, he was a Managing Director with MBF Healthcare Partners, which is a middle-market healthcare-focused private equity fund. At MBF, he served on the Board of Directors for Carisk (Behavioral Health/ Catastrophic Care Management), Acorn Health (Autism Services in Home and Clinic), Strive Dental Management (Dental Service Organization), and Affinity Hospice. Prior to MBF, he was with Apple Tree Partners ("ATP"), a $1.5 billion healthcare-focused growth equity fund. During his time at ATP, he served as the interim CEO and a board member at Cure Forward (precision medicine technology platform) in addition to being actively involved with Clean Slate Addiction Treatment Centers, TripleCare (telemedicine for SNFs), and QualDerm Partners (dermatology practices). He has held other roles in private equity and investment banking (both M & A as well as leveraged finance) including time at The Beekman Group, a middle-market private equity fund, and CIT Group, a middle-market investment bank. He earned an MBA from Columbia Business School, where he achieved Dean's Honors and Distinction and holds a BS in business administration from Boston University's School of Management, where he graduated magna cum laude. He serves as Board Member at H2 Health.